367 related articles for article (PubMed ID: 18564685)
21. Distribution of capsular serotypes and macrolide resistance mechanisms among macrolide-resistant Streptococcus pneumoniae isolates in Korea.
Bae S; Lee K
Diagn Microbiol Infect Dis; 2009 Feb; 63(2):213-6. PubMed ID: 19097840
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of moxifloxacin for treatment of penicillin-, macrolide- and multidrug-resistant Streptococcus pneumoniae in community-acquired pneumonia.
Fogarty C; Torres A; Choudhri S; Haverstock D; Herrington J; Ambler J
Int J Clin Pract; 2005 Nov; 59(11):1253-9. PubMed ID: 16236076
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial susceptibilities of Streptococcus pneumoniae isolated from adult patients with community-acquired pneumonia in Japan.
Ishida T; Maniwa K; Kagioka H; Hirabayashi M; Onaru K; Tomioka H; Hayashi M; Tomii K; Gohma I; Ito Y; Hirai T; Ito I; Mishima M
Respirology; 2008 Mar; 13(2):240-6. PubMed ID: 18339022
[TBL] [Abstract][Full Text] [Related]
24. Distribution and antibacterial susceptibility of macrolide resistance genotypes in Streptococcus pneumoniae: PROTEKT Year 5 (2003-2004).
Farrell DJ; Couturier C; Hryniewicz W
Int J Antimicrob Agents; 2008 Mar; 31(3):245-9. PubMed ID: 18178388
[TBL] [Abstract][Full Text] [Related]
25. Surveillance for penicillin-nonsusceptible Streptococcus pneumoniae--New York City, 1995.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Apr; 46(14):297-9. PubMed ID: 9132581
[TBL] [Abstract][Full Text] [Related]
26. [The Viriato Study: update of antimicrobial susceptibility data of bacterial pathogens from community-acquired respiratory tract infections in Portugal in 2001 and 2002].
Melo-Cristino J; Serrano N;
Rev Port Pneumol; 2003; 9(4):293-310. PubMed ID: 19771688
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ
Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
[TBL] [Abstract][Full Text] [Related]
28. A survey of antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae in Turkey, 2004 2005.
Sener B; Tunçkanat F; Ulusoy S; Tünger A; Söyletir G; Mülazimoğlu L; Gürler N; Oksüz L; Köksal I; Aydin K; Yalçin AN; Oğünç D; Acar A; Sievers J
J Antimicrob Chemother; 2007 Sep; 60(3):587-93. PubMed ID: 17597058
[TBL] [Abstract][Full Text] [Related]
29. [Streptococcus pneumoniae meningitis in Amiens Hospital between 1990 and 2005. Bacteriological characteristics of strains isolated].
Hamdad F; Canarelli B; Rousseau F; Thomas D; Biendo M; Eb F; Varon E; Laurans G
Pathol Biol (Paris); 2007 Nov; 55(8-9):446-52. PubMed ID: 17905533
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic and genotypic characterization of macrolide resistant Streptococcus pneumoniae recovered from adult patients with community-acquired pneumonia in an Argentinian teaching hospital.
Bonofiglio L; Ojeda MI; de Mier C; Vay C; Famiglietti A; Gutkind G; Mollerach M
Int J Antimicrob Agents; 2005 Mar; 25(3):260-3. PubMed ID: 15737523
[TBL] [Abstract][Full Text] [Related]
31. [Current use of penicillin in community-acquired pneumococcal pneumonias].
Gaztelurrutia L; Zalacaín R; Rubio G; Hernández JL; Urra E; Hernández M; Garea C; Barrón J
Enferm Infecc Microbiol Clin; 1994 Jan; 12(1):17-20. PubMed ID: 8155749
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic options for pneumococcal pneumonia in Turkey.
Oncu S; Erdem H; Pahsa A
Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
[TBL] [Abstract][Full Text] [Related]
33. Pneumococci: drug susceptibilities and preliminary epidemiological studies by penicillin binding protein genotyping.
Srifeungfung S; Thammawart S; Leelarasamee A; Chokephaibulkit K; Dejsirilert S; Tribuddharat C
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):658-62. PubMed ID: 16124434
[TBL] [Abstract][Full Text] [Related]
34. High prevalence of multidrug-resistant Pneumococcal molecular epidemiology network clones among Streptococcus pneumoniae isolates from adult patients with community-acquired pneumonia in Japan.
Imai S; Ito Y; Ishida T; Hirai T; Ito I; Maekawa K; Takakura S; Iinuma Y; Ichiyama S; Mishima M;
Clin Microbiol Infect; 2009 Nov; 15(11):1039-45. PubMed ID: 19694764
[TBL] [Abstract][Full Text] [Related]
35. 10th survey of antimicrobial resistance in noninvasive clinical isolates of Streptococcus pneumoniae collected in Belgium during winter 2007-2008.
Vanhoof R; Camps K; Carpentier M; De Craeye S; Frans J; Glupczynski Y; Goffinet P; Gordts B; Govaerts D; Ide L; Lefèvre P; Lontie M; Cartuyvels R; Meunier F; Mulongo B; Philippart I; Surmont I; Van Bossuyt E; Van Eldere J; Verhaegen J
Pathol Biol (Paris); 2010 Apr; 58(2):147-51. PubMed ID: 19892491
[TBL] [Abstract][Full Text] [Related]
36. Antibacterial resistance patterns in Streptococcus pneumoniae isolated from elderly patients: PROTEKT years 1-5 (1999-2004).
Cantón R; Unal S; Farrell DJ
Int J Antimicrob Agents; 2007 Dec; 30(6):546-50. PubMed ID: 17931834
[TBL] [Abstract][Full Text] [Related]
37. Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?
Falcó V; Almirante B; Jordano Q; Calonge L; del Valle O; Pigrau C; Planes AM; Gavaldà J; Pahissa A
J Antimicrob Chemother; 2004 Aug; 54(2):481-8. PubMed ID: 15215226
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens.
Song JH; Jung SI; Ki HK; Shin MH; Ko KS; Son JS; Chang HH; Kim SW; Lee H; Kim YS; Oh WS; Peck KR; Chongthaleong A; Lalitha MK; Perera J; Yee TT; Jamal F; Kamarulzaman A; Carlos CC; So T;
Clin Infect Dis; 2004 Jun; 38(11):1570-8. PubMed ID: 15156445
[TBL] [Abstract][Full Text] [Related]
39. [In vitro resistance rates of Streptococcus pneumoniae and Haemophilus influenzae clinical isolates to the antibiotics used in therapy].
Uncu H; Colakoğlu S; Turunç T; Demiroğlu YZ; Arslan H
Mikrobiyol Bul; 2007 Jul; 41(3):441-6. PubMed ID: 17933256
[TBL] [Abstract][Full Text] [Related]
40. Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes?
Rothermel CD
Clin Infect Dis; 2004 May; 38 Suppl 4():S346-9. PubMed ID: 15127368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
